Role of TET2and ASXL1Mutations in the Pathogenesis of Myeloproliferative Neoplasms
Since the discovery of activating mutations in JAK2 in patients with myeloproliferative neoplasms (MPNs) in 2005, gene discovery efforts have identified additional disease alleles, which can predate or occur subsequent…